Coil plus glue versus glue alone for bleeding stomach veins in cirrhosis
Compares two endoscopic treatments for bleeding gastric varices in people with cirrhosis.
Key facts
- Who runs it
- Medanta, The Medicity, India
- Where
- Orlando, United StatesSee the siteAlso in 1 other country, 1 site
- Trial code
- Registry title
- EUS-Guided Coil and Glue vs Glue Injection for Bleeding Gastric Varices in Cirrhosis
- Status
- Recruiting
- People taking part
- 110 people, planned
- Started
- Sept 2026
- Expected to end
- Jun 2028
- Type of study
- Interventional, 2 groupsOne group gets an existing treatment, for comparison.
- Treatments tested
- EUS-guided Coil and Cyanoacrylate Glue Injection
- Endoscopic Cyanoacrylate Glue Injection
- Record updated
- 6 October 2026
Who can take part
AI summary
From the trial's eligibility criteria. Machine-read from the registry text on this page, so it can be wrong. The registry text below and the trial team decide who can take part.
The trial is looking for adults with liver cirrhosis and portal hypertension who may be bleeding from certain stomach veins (gastric varices). It compares two ways of closing these veins with glue, one also using coils.
- Age
- Over 18 years (minimum 19 years)
- Sex
- All sexes
- Disease stage
- Confirmed liver cirrhosis with portal hypertension (high pressure in the liver's blood vessels). Suspected bleeding from varices in the upper stomach, type GOV-2 or IGV-1.
Main reasons for not taking part
- Bleeding from food-pipe varices (EV), GOV-1 or IGV2
- Portal hypertension without cirrhosis
- Blood actively spurting from the stomach varices at endoscopy
- Pregnancy, shock that does not respond to treatment, sepsis or ACLF (sudden liver failure on top of long-term liver disease)
- Platelet count < 50,000 /mL and INR > 2.0, or unable to have endoscopy
The registry criteria, word for word
Show all 12 criteriaShow less
Who can take part
- Age > 18 years
- Confirmed diagnosis of liver cirrhosis with portal hypertension
- Patients presenting with suspected bleed from cardio-fundal varices, specifically classified as gastroesophageal varices type-2 (GOV-2) or isolated gastric varices type-1 (IGV-1)
Who cannot take part
- Patients experiencing bleeding from esophageal varices (EV) or gastroesophageal varices type-1 (GOV-1) or IGV2
- Patients with non-cirrhotic portal hypertension
- Platelet count < 50,000 /mL and International Normalized Rate (INR) > 2.0
- Active spurt of blood noted from gastric varices seen on endoscopy
- Pregnancy
- Patients with refractory shock
- Sepsis/ACLF
- Contraindication to endoscopy
- Not willing to provide consent
Where in United States
Also in 1 other country, 1 site
- Orlando Health Orlando Regional Medical CenterOrlando, United StatesContact: Dr shyam, MDNot yet recruiting
About the trial
What the trial wants to find out
Gastric variceal bleeding is a life-threatening complication of portal hypertension in patients with cirrhosis and is associated with significant morbidity and mortality. Endoscopic cyanoacrylate glue injection is the current standard treatment; however, recurrent bleeding and procedure-related complications remain important concerns. Endoscopic ultrasound (EUS)-guided coil and cyanoacrylate glue injection has emerged as a promising alternative that may improve variceal obliteration and reduce rebleeding rates.
Read full original descriptionShow less
This prospective, randomized, open-label, parallel-group trial will compare EUS-guided coil and cyanoacrylate glue injection with conventional endoscopic cyanoacrylate glue injection in patients with cirrhosis presenting with bleeding gastric varices. A total of 158 participants will be randomized in a 1:1 ratio to either treatment arm. The primary outcome is all-cause rebleeding at 12 months. Secondary outcomes include technical success, early and late rebleeding, number of treatment sessions required for variceal obliteration, glue volume used, procedure-related adverse events, hepatic decompensation, duration of hospital stay, cost of treatment, and mortality.
The 2 groups in the trial
- EUS-guided Coil and Glue InjectionTreatment being tested
Participants randomized to this arm will undergo endoscopic ultrasound (EUS)-guided treatment of bleeding gastric varices using embolization coils followed by cyanoacrylate glue injection. Additional EUS-guided treatment will be performed during follow-up if residual Doppler flow is present until complete variceal obliteration is achieved. Participants will undergo scheduled follow-up for 12 months with clinical assessment, EUS surveillance, and laboratory investigations.
Treatment: EUS-guided Coil and Cyanoacrylate Glue Injection
- Endoscopic Glue InjectionExisting treatment, for comparison
Participants randomized to this arm will undergo conventional endoscopic cyanoacrylate glue injection for treatment of bleeding gastric varices. Additional endoscopic glue injection will be performed during follow-up if residual varices are present until complete variceal obliteration is achieved. Participants will undergo scheduled follow-up for 12 months with clinical assessment, surveillance endoscopy, and laboratory investigations.
Treatment: Endoscopic Cyanoacrylate Glue Injection
Questions to ask the study team
- How often do I need to come in, and for how long each time?
- Are travel costs paid?
- Can I keep my own doctor?
- What happens if I want to stop?
Contact the study team: see the registry record → Contacts and Locations
Print a page for my doctorData and sources
- Registry record
- Listed on ClinicalTrials.gov.
- Official title
- Endoscopic Ultrasound-Guided Coil and Glue Injection Versus Endoscopic Glue Injection in Patients With Cirrhosis and Gastric Variceal Bleed: An Open Label Randomized Controlled Trial
- Plain-language title
- Coil plus glue versus glue alone for bleeding stomach veins in cirrhosisGenerated from the registry record. The registry title is the official one.
- AI summary
- From the trial's eligibility criteria. Read by machine on 14 November 2026.
- Record updated
- 6 October 2026